Moneycontrol
HomeNewscoronavirusMaharashtra lockdown | 5 million retail jobs at stake: Shopping Centres Association

Maharashtra lockdown | 5 million retail jobs at stake: Shopping Centres Association

The lockdown has also put plans of more than 30 malls on hold, which are currently under construction.

July 20, 2020 / 19:01 IST
Story continues below Advertisement
Representative image

The Shopping Centres Association of India (SCAI) has written to Maharashtra Tourism Minister Aaditya Thackeray urging him and the state government to take concrete steps to urgently open malls in the state.

Maharashtra has more than 75 malls across the state, with almost 50 percent spread across Mumbai Metropolitan Region (MMR), Thane, Kalyan, Navi Mumbai, Dombivli, etc. Similarly, Pune has more than 20 percent malls while the rest are spread across Amravati, Aurangabad, Kolhapur, Nashik, Nagpur, Aurangabad, etc.

Story continues below Advertisement

The lockdown has also put plans of more than 30 malls on hold, which are currently under construction.

In its letter to Thackeray, SCAI has hinted that 5 million people involved in modern retail may lose their jobs if urgent action is not taken by the state government. This is being seen as a result of the revenue freeze following the lockdown, which has impacted the entire retail industry.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show